• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537291
INE448G01010
341.3302463
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATHBIOGEN
9.87
410.77
EPS(TTM)
Face Value()
Div & Yield %
21.89
10
0.93
 

Nath Bio-Genes (India) consolidated net profit declines 43.51% in the March 2025 quarter
Apr 30,2025
Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024.

For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales51.9743.04 21 364.91332.62 10
OPM %0.819.13 -13.6414.99 -
PBDT2.913.27 -11 43.8641.38 6
PBT1.572.28 -31 40.0438.11 5
NP1.482.62 -44 38.6039.62 -3